Skinvisible (SKVI) Equity Average (2016 - 2026)
Skinvisible's Equity Average history spans 15 years, with the latest figure at -$10.1 million for Q4 2025.
- On a quarterly basis, Equity Average fell 6.16% to -$10.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$10.1 million, a 6.16% decrease, with the full-year FY2025 number at -$9.7 million, down 6.79% from a year prior.
- Equity Average hit -$10.1 million in Q4 2025 for Skinvisible, down from -$9.9 million in the prior quarter.
- Over the last five years, Equity Average for SKVI hit a ceiling of -$4.7 million in Q1 2021 and a floor of -$10.1 million in Q4 2025.
- Historically, Equity Average has averaged -$7.7 million across 5 years, with a median of -$8.4 million in 2023.
- Biggest five-year swings in Equity Average: crashed 45.01% in 2021 and later fell 1.59% in 2025.
- Tracing SKVI's Equity Average over 5 years: stood at -$5.4 million in 2021, then decreased by 20.1% to -$6.4 million in 2022, then tumbled by 37.74% to -$8.9 million in 2023, then fell by 7.6% to -$9.5 million in 2024, then decreased by 6.16% to -$10.1 million in 2025.
- Business Quant data shows Equity Average for SKVI at -$10.1 million in Q4 2025, -$9.9 million in Q3 2025, and -$9.6 million in Q2 2025.